Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyWei Wang, Shimin Hu, Joseph A. DiGiuseppe et al.|Blood|2016Cited by 191
A global study for acute myeloid leukemia with <i>RARG</i> rearrangementHong‐Hu Zhu, Suning Chen, Ya‐Zhen Qin et al.|Blood Advances|2023Cited by 26
Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family–negative T-prolymphocytic leukemiaHong Fang, Wei Wang|American Journal of Clinical Pathology|2024Cited by 4